Clinical Trial Update: Zorifertinib With Osimertinib for NSCLC With Meningeal Progression [Phase 1]

View source ↗

Summary

The document reports a Phase 1 clinical trial evaluating Zorifertinib in combination with Osimertinib for patients with advanced non-small cell lung cancer and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Osimertinib (osimertinib)
• Zorifertinib (Zorifertinib)

Snippet

Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. | Conditions: Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment | Phase 1 | Status: NOT_YET_RECRUITING